Andras Ruppert

Vice President
Andras Ruppert | Life Sciences | Charles River Associates

Andras Ruppert is a vice president in the Life Sciences Practice at CRA. He has more than 20 years of experience working in the pharmaceutical, biotech, and medical device industries globally, solving strategic issues.

Mr. Ruppert is an expert in European healthcare systems, including their funding, evaluation, and reimbursement processes.  He also helps life sciences companies to adjust internal structures and processes to the changing environment.

Prior to his role at CRA, Mr. Ruppert held senior positions at QuintilesIMS, now doing business as IQVIA, most recently as a vice president and head of their global consulting business out of Europe. He is fluent in English, German, and Norwegian.

Selected engagements

  • 01
    Market access strategy for a device/App combination in diabetes
    A leading diabetes device manufacturer sought CRA’s support in developing a healthcare market access launch strategy.
    View engagement
  • 02
    CRA evaluates commercial efforts to develop a MS drug with respect to contractual obligations following merger
    CRA assessed commercial efforts to develop and commercialize a MS drug with respect to obligations stemming from the acquisition of Genzyme Corporation by...
    View engagement
  • 03
    Determining the optimal MedTech market access strategy to enter in UK, Nordics
    A medical devices company marketing a patient-used device sought MedTech market access support to enter more countries.
    View engagement

Credentials